DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRCIVEX (Q2019366)

From EU Knowledge Graph
Revision as of 04:48, 2 November 2020 by DG Regio (talk | contribs) (‎Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement)
Jump to navigation Jump to search
Project Q2019366 in Italy
Language Label Description Also known as
English
DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRCIVEX
Project Q2019366 in Italy

    Statements

    0 references
    986,675.87 Euro
    0 references
    1,329,656.71 Euro
    0 references
    74.21 percent
    0 references
    1 November 2016
    0 references
    31 December 2018
    0 references
    NOUSCOM SOCIETA' A RESPONSABILITA' LIMITATA
    0 references
    0 references
    BIOTECNOLOGIE (Italian)
    0 references
    BIOTECHNOLOGY (English)
    0 references

    Identifiers

    B88I17000390008
    0 references